Percutaneous Coronary Intervention
Conditions
Brief summary
High rates of recurrent cardiovascular events and readmission after percutaneous coronary intervention (PCI) are important issues. Guidelines emphasize rehabilitation and secondary prevention. But many patients are lack of effective management after PCI.This study is aimed to examine the effect of mobile application (APP)-based multifaceted management on the improvement of long-term care after PCI.
Detailed description
This is a cluster-randomized controlled trial to evaluate the effect of APP-based multifaceted management strategy on improvement of long-term care for medication adherence,risk factor control, and reduction of adverse events, readmission rate and mortality after PCI.It includes knowledge education, medication reminder,advice provision, support to change lifestyle behaviors. The program is interactive between care provider and patients. A total of 20 wards will be randomly assigned to intervention or usual care.Anticipated 1100 patients after PCI will be participated in the trial. All the participants will be followed up until 12 months.
Interventions
OTHERAPP-based multifaceted management
Patients after PCI will be regularly given education materials, medication reminders, life-style behaviors instruction through APP. Cardiologists can interact with patients on advice provision and clinical support after discharge through APP.
Sponsors
Chinese Academy of Medical Sciences, Fuwai Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* patients who have received percutaneous coronary intervention and are discharged alive in the study centers; * patients who are able to use APP; * patients who provide informed consent.
Exclusion criteria
* patients who are not able to use APP; * dementia; * mental disturbed; * patients who are not willing to receive management and follow up.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications) | at 12 months after PCI | the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| rate of LDL-C achieving target | at 12 months after PCI | rate of LDL-C achieving target based on guideline |
| rate of systolic blood pressure achieving target | at 12 months after PCI | rate of systolic blood pressure achieving target based on guideline |
| readmission rate | 12 months after PCI | readmission rate after PCI |
Other
| Measure | Time frame | Description |
|---|---|---|
| smoking status (the proportion of participants with smoking cessation) | at 12 months after PCI | the proportion of participants with smoking cessation |
| rehabilitation (the proportion of participants who receive rehabilitation program) | 12 months after PCI | the proportion of participants who receive rehabilitation program |
Contacts
Primary ContactHAIYAN XU
Outcome results
None listed